Aug 16, 2019 · Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes. The presence of tumor-infiltrating lymphocytes (TILs) is correlated with good prognosis and outcome after (immuno)therapy in triple-negative and HER2-positive breast cancer. This page highlights recent research in the detection and treatment of breast cancer. New methods to detect breast cancer, such as 3-D mammography, are described. Treatments tailored to breast cancer subtypes are discussed, including targeted therapies.
Considering information about the clinical risk of recurrence of early-stage breast cancer along with the Oncotype DX Recurrence Score results can help refine which women age 50 and younger diagnosed with early-stage hormone-receptor-positive, HER2-negative breast cancer that has not spread to the lymph nodes with a Recurrence Score of 16 to 25. Breast Cancer Research is an international, peer-reviewed online journal, publishing original research, reviews, editorials and reports. Open access research articles of exceptional interest are published in all areas of biology and medicine relevant to breast cancer, including normal mammary gland biology, with special emphasis on the genetic, biochemical, and cellular basis of breast cancer.
Rugo H.S. | N Engl J Med 2019; 381:371-372 Breast cancer is the most common cancer diagnosis in young women.1 In the United States, the incidence of breast . Breast Cancer Research is the highest ranking breast cancer-specific title in the top quartile of oncology journals worldwide. Primarily publishing original research, literature reviews, and invited editorials, the journal also publishes preclinical, translational and clinical studies with a biological basis, including Phase I and Phase II trials.
Jun 01, 2019 · Younger women with breast cancer have been given the hope of living longer after what is described as “one of the greatest advances in breast cancer research in recent decades”. Adding Author: Jamie Doward. Clinical Breast Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of breast cancer. Clinical Breast Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is on recent scientific developments.